ClinicalTrials.Veeva

Menu

Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (HYPOMASLD)

U

University of Trieste

Status

Not yet enrolling

Conditions

Normobaric Hypoxia
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Treatments

Other: HYPOTRAIN
Other: NORMOTRAIN

Study type

Interventional

Funder types

Other

Identifiers

NCT07073326
DSM_FisioMedSport_Hypoxic25

Details and patient eligibility

About

Altitude training has been suggested to be of potential support to improve some chronic clinical conditions, especially metabolic conditions. Normobaric hypoxia represents a promising system to simulate altitude training, and its efficacy and safety have been suggested in different conditions, including diabetes, obesity and hypertension. Metabolic dysfunction-associated steatotic liver disease (MASLD) can characterized by metabolic alterations (including altered body composition, lipid and glycemic profile, etc.), and might benefit from aerobic training performed in simulated altitude training (i.e., normobaric hypoxia). Mild altitude training will be proposed (equal to about 2'500 m, 15% FiO2) and compared to a sham normobaric normoxia condition, during an 8-week 3 or 2 times per week 1-h aerobic training (walking) at 60-65% of maximum heart rate (HRmax). Cardiorespiratory fitness, body composition, and metabolic profile will be investigated.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being diagnosed with MASLD from at the least 3 years
  • BMI > 26 kg/m2
  • Being sedentary

Exclusion criteria

  • Cardiovascular, respiratory, renal complications
  • Hypertension
  • COPD
  • Previous history of acute mountain sickness or altitude-associated symptoms
  • Females only: pregnancy or breastfeeding

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

HYPOTRAIN
Experimental group
Description:
This arm will perform the normobaric hypoxic aerobic training (HYPOTRAIN)
Treatment:
Other: HYPOTRAIN
NORMOTRAIN
Sham Comparator group
Description:
This arm will perform the normobaric normoxia aerobic training (NORMOTRAIN)
Treatment:
Other: NORMOTRAIN

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems